330 related articles for article (PubMed ID: 32930582)
21. Pharmacological activity of salvinorin A, the major component of Salvia divinorum.
Listos J; Merska A; Fidecka S
Pharmacol Rep; 2011; 63(6):1305-9. PubMed ID: 22358078
[TBL] [Abstract][Full Text] [Related]
22. Chemical syntheses of the salvinorin chemotype of KOR agonist.
Hill SJ; Brion AUCM; Shenvi RA
Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003
[TBL] [Abstract][Full Text] [Related]
23. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
[TBL] [Abstract][Full Text] [Related]
24. Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands.
Takayama H; Ishikawa H; Kurihara M; Kitajima M; Aimi N; Ponglux D; Koyama F; Matsumoto K; Moriyama T; Yamamoto LT; Watanabe K; Murayama T; Horie S
J Med Chem; 2002 Apr; 45(9):1949-56. PubMed ID: 11960505
[TBL] [Abstract][Full Text] [Related]
25. O6C-20-nor-salvinorin A is a stable and potent KOR agonist.
Hirasawa S; Cho M; Brust TF; Roach JJ; Bohn LM; Shenvi RA
Bioorg Med Chem Lett; 2018 Sep; 28(16):2770-2772. PubMed ID: 29426768
[TBL] [Abstract][Full Text] [Related]
26. Oxidative Metabolism as a Modulator of Kratom's Biological Actions.
Chakraborty S; Uprety R; Slocum ST; Irie T; Le Rouzic V; Li X; Wilson LL; Scouller B; Alder AF; Kruegel AC; Ansonoff M; Varadi A; Eans SO; Hunkele A; Allaoa A; Kalra S; Xu J; Pan YX; Pintar J; Kivell BM; Pasternak GW; Cameron MD; McLaughlin JP; Sames D; Majumdar S
J Med Chem; 2021 Nov; 64(22):16553-16572. PubMed ID: 34783240
[TBL] [Abstract][Full Text] [Related]
27. Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.
Smith MT; Kong D; Kuo A; Imam MZ; Williams CM
J Med Chem; 2022 Feb; 65(3):1612-1661. PubMed ID: 34995453
[TBL] [Abstract][Full Text] [Related]
28. Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.
Sherwood AM; Crowley RS; Paton KF; Biggerstaff A; Neuenswander B; Day VW; Kivell BM; Prisinzano TE
J Med Chem; 2017 May; 60(9):3866-3878. PubMed ID: 28376298
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor.
Watanabe K; Yano S; Horie S; Yamamoto LT
Life Sci; 1997; 60(12):933-42. PubMed ID: 9061050
[TBL] [Abstract][Full Text] [Related]
30. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
[TBL] [Abstract][Full Text] [Related]
31. Salvinorin A analogs as probes in opioid pharmacology.
Prisinzano TE; Rothman RB
Chem Rev; 2008 May; 108(5):1732-43. PubMed ID: 18476672
[No Abstract] [Full Text] [Related]
32. Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists.
Kaserer T; Steinacher T; Kainhofer R; Erli F; Sturm S; Waltenberger B; Schuster D; Spetea M
Sci Rep; 2020 Aug; 10(1):13804. PubMed ID: 32796875
[TBL] [Abstract][Full Text] [Related]
33. Total Synthesis and Structural Plasticity of Kratom Pseudoindoxyl Metabolites.
Angyal P; Hegedüs K; Mészáros BB; Daru J; Dudás Á; Galambos AR; Essmat N; Al-Khrasani M; Varga S; Soós T
Angew Chem Int Ed Engl; 2023 Aug; 62(35):e202303700. PubMed ID: 37332089
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats.
Carpenter JM; Criddle CA; Craig HK; Ali Z; Zhang Z; Khan IA; Sufka KJ
Fitoterapia; 2016 Mar; 109():87-90. PubMed ID: 26688378
[TBL] [Abstract][Full Text] [Related]
35. Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy.
Harun N; Kamaruzaman NA; Mohamed Sofian Z; Hassan Z
Neurosci Lett; 2022 Mar; 773():136500. PubMed ID: 35114335
[TBL] [Abstract][Full Text] [Related]
36. Nature's first "atypical opioids": Kratom and mitragynines.
Raffa RB; Pergolizzi JV; Taylor R; Ossipov MH;
J Clin Pharm Ther; 2018 Jun; 43(3):437-441. PubMed ID: 29520812
[TBL] [Abstract][Full Text] [Related]
37. Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.
Lozama A; Cunningham CW; Caspers MJ; Douglas JT; Dersch CM; Rothman RB; Prisinzano TE
J Nat Prod; 2011 Apr; 74(4):718-26. PubMed ID: 21338114
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
[TBL] [Abstract][Full Text] [Related]
39. Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.
Fichna J; Schicho R; Janecka A; Zjawiony JK; Storr M
Drug News Perspect; 2009 Sep; 22(7):383-92. PubMed ID: 19890495
[TBL] [Abstract][Full Text] [Related]
40. A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects.
Chakraborty S; DiBerto JF; Faouzi A; Bernhard SM; Gutridge AM; Ramsey S; Zhou Y; Provasi D; Nuthikattu N; Jilakara R; Nelson MNF; Asher WB; Eans SO; Wilson LL; Chintala SM; Filizola M; van Rijn RM; Margolis EB; Roth BL; McLaughlin JP; Che T; Sames D; Javitch JA; Majumdar S
J Med Chem; 2021 Sep; 64(18):13873-13892. PubMed ID: 34505767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
